GP

Graft Polymer (UK) PlcLSE Graft Polymer Stock Report

Last reporting period 30 Jun, 2023

Updated 29 Oct, 2024

Last price

Market cap $B

0.004

Micro

Exchange

XLON - London Stock Exchange

GPL.L Stock Analysis

GP

Uncovered

Graft Polymer (UK) Plc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.004

Dividend yield

Shares outstanding

104.1 B

Graft Polymer (UK) Ltd. is a holding company, which comprises polymer modification and drug delivery systems developments. The firm's primary business comprises polymer modification and the development of drug delivery systems. The firm offers bespoke, adapted, and tailored products for customer requests. The Company’s products pipeline includes GRAFTABOND, GRAFTAPOR, GRAFTALEN, GRAFTAKIT, GRAFTALLOY, GRAFTAMID, GRAFTASYNT and GRAFTAMER. GRAFTABOND product is a graft / block copolymers (adhesion promotors) for combining various polymers (with fiberglass, carbon fiber, mineral and natural fillers, mixed polymer waste. The GRAFTAPOR product is a porous polymer carriers for many liquid chemicals. The firm's GRAFTALEN product is a reactive solid super concentrates for polyolefin rheology modification, e-modulus enhancer, polybutylene terephthalate chain extender, AOX masterbatch. Its GRAFTAKIT is a reactive liquid or solid super concentrates on polymeric porous media for carrying out reaction extrusion and modification of compounds.

View Section: Eyestock Rating